These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

670 related items for PubMed ID: 12838339

  • 1. Phospholamban: a crucial regulator of cardiac contractility.
    MacLennan DH, Kranias EG.
    Nat Rev Mol Cell Biol; 2003 Jul; 4(7):566-77. PubMed ID: 12838339
    [Abstract] [Full Text] [Related]

  • 2. Phospholamban and cardiac contractility.
    Frank K, Kranias EG.
    Ann Med; 2000 Nov; 32(8):572-8. PubMed ID: 11127935
    [Abstract] [Full Text] [Related]

  • 3. Phospholamban: a promising therapeutic target in heart failure?
    Schmidt AG, Edes I, Kranias EG.
    Cardiovasc Drugs Ther; 2001 Sep; 15(5):387-96. PubMed ID: 11855657
    [Abstract] [Full Text] [Related]

  • 4. Sarcoplasmic reticulum Ca-ATPase-phospholamban interactions and dilated cardiomyopathy.
    Haghighi K, Gregory KN, Kranias EG.
    Biochem Biophys Res Commun; 2004 Oct 01; 322(4):1214-22. PubMed ID: 15336969
    [Abstract] [Full Text] [Related]

  • 5. Targeted overexpression of phospholamban to mouse atrium depresses Ca2+ transport and contractility.
    Neumann J, Boknik P, DePaoli-Roach AA, Field LJ, Rockman HA, Kobayashi YM, Kelley JS, Jones LR.
    J Mol Cell Cardiol; 1998 Oct 01; 30(10):1991-2002. PubMed ID: 9799653
    [Abstract] [Full Text] [Related]

  • 6. [Cardiac sarcoplasmic reticulum and phospholamban].
    Tada M, Toyofuku T, Yabuki M.
    Tanpakushitsu Kakusan Koso; 1998 Sep 01; 43(12 Suppl):1622-7. PubMed ID: 9788161
    [No Abstract] [Full Text] [Related]

  • 7. Phospholamban: a protein coming of age.
    Kadambi VJ, Kranias EG.
    Biochem Biophys Res Commun; 1997 Oct 09; 239(1):1-5. PubMed ID: 9345259
    [Abstract] [Full Text] [Related]

  • 8. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy.
    Minamisawa S, Hoshijima M, Chu G, Ward CA, Frank K, Gu Y, Martone ME, Wang Y, Ross J, Kranias EG, Giles WR, Chien KR.
    Cell; 1999 Oct 29; 99(3):313-22. PubMed ID: 10555147
    [Abstract] [Full Text] [Related]

  • 9. Phospholamban: a key determinant of cardiac function and dysfunction.
    Rodriguez P, Kranias EG.
    Arch Mal Coeur Vaiss; 2005 Dec 29; 98(12):1239-43. PubMed ID: 16435604
    [Abstract] [Full Text] [Related]

  • 10. Cardiac-specific overexpression of sarcolipin in phospholamban null mice impairs myocyte function that is restored by phosphorylation.
    Gramolini AO, Trivieri MG, Oudit GY, Kislinger T, Li W, Patel MM, Emili A, Kranias EG, Backx PH, Maclennan DH.
    Proc Natl Acad Sci U S A; 2006 Feb 14; 103(7):2446-51. PubMed ID: 16461894
    [Abstract] [Full Text] [Related]

  • 11. Phospholamban and cardiac contractile function.
    Brittsan AG, Kranias EG.
    J Mol Cell Cardiol; 2000 Dec 14; 32(12):2131-9. PubMed ID: 11112989
    [No Abstract] [Full Text] [Related]

  • 12. Alterations of phospholamban function can exhibit cardiotoxic effects independent of excessive sarcoplasmic reticulum Ca2+-ATPase inhibition.
    Schmitt JP, Ahmad F, Lorenz K, Hein L, Schulz S, Asahi M, Maclennan DH, Seidman CE, Seidman JG, Lohse MJ.
    Circulation; 2009 Jan 27; 119(3):436-44. PubMed ID: 19139388
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Function and role of the sarcoplasmic reticulum in heart disease].
    Reyes-Juárez JL, Zarain-Herzberg A.
    Arch Cardiol Mex; 2006 Jan 27; 76 Suppl 4():S18-32. PubMed ID: 17469332
    [Abstract] [Full Text] [Related]

  • 15. PKC-alpha regulates cardiac contractility and propensity toward heart failure.
    Braz JC, Gregory K, Pathak A, Zhao W, Sahin B, Klevitsky R, Kimball TF, Lorenz JN, Nairn AC, Liggett SB, Bodi I, Wang S, Schwartz A, Lakatta EG, DePaoli-Roach AA, Robbins J, Hewett TE, Bibb JA, Westfall MV, Kranias EG, Molkentin JD.
    Nat Med; 2004 Mar 27; 10(3):248-54. PubMed ID: 14966518
    [Abstract] [Full Text] [Related]

  • 16. Interactions of the calcium ATPase with phospholamban and sarcolipin: structure, physiology and pathophysiology.
    Maclennan DH.
    J Muscle Res Cell Motil; 2004 Mar 27; 25(8):600-1. PubMed ID: 16118852
    [No Abstract] [Full Text] [Related]

  • 17. Cardiac sarcoplasmic reticulum function and regulation of contractility. Introduction.
    Johnson RG, Kranias EG.
    Ann N Y Acad Sci; 1998 Sep 16; 853():xi-xvi. PubMed ID: 10603930
    [No Abstract] [Full Text] [Related]

  • 18. Sarcoplasmic reticulum Ca2+ refilling controls recovery from Ca2+-induced Ca2+ release refractoriness in heart muscle.
    Szentesi P, Pignier C, Egger M, Kranias EG, Niggli E.
    Circ Res; 2004 Oct 15; 95(8):807-13. PubMed ID: 15388639
    [Abstract] [Full Text] [Related]

  • 19. The relative phospholamban and SERCA2 ratio: a critical determinant of myocardial contractility.
    Koss KL, Grupp IL, Kranias EG.
    Basic Res Cardiol; 1997 Oct 15; 92 Suppl 1():17-24. PubMed ID: 9202840
    [Abstract] [Full Text] [Related]

  • 20. Increased cardiomyocyte function and Ca2+ transients in mice during early congestive heart failure.
    Mørk HK, Sjaastad I, Sande JB, Periasamy M, Sejersted OM, Louch WE.
    J Mol Cell Cardiol; 2007 Aug 15; 43(2):177-86. PubMed ID: 17574269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.